Table 1.
Demographics | Failure group (n = 28) | Success group (n = 15) | P |
Age, yr | 39.0 (32.0–45.0) | 37.0 (33.0–42.0) | .006 |
BMI, kg/m2 | 22.0 (18.0–29.0) | 21.8 (15.0–29.0) | .908 |
Gravida | 0 (0–8) | 1 (0–3) | .685 |
Parity | 0 (0–1) | 0 (0) | .295 |
Symptom | |||
Pain score (NRS) | 8 (7–10, n = 20) | 8.0 (1–10, n = 13) | .609 |
Menorrhagia (n) | 24 (85.7%) | 10 (66.7%) | .238 |
AMH, ng/mL | 0.54 (0.01–8.54) | 2.91 (0.34–7.92) | .002 |
CA125, IU/mL | 151.5 (13.0–809.1) | 182.0 (29.2–1388) | .752 |
Infertility duration (yr) | 5.0 (0–16) | 3.0 (0–11) | .119 |
Preoperative uterine volume, cm3 | 353.67 (93.0–2097.7) | 327.76 (134.4–743.6) | .262 |
Nodule weight, g | 123.5 (3.0–320.0) | 90.0 (3.0–240.0) | .333 |
Operative time, min | 220.0 (68.0–440.0) | 175.0 (65.0–305.0) | .048 |
EBL, mL | 750 (100–2500) | 500 (50–2000) | .016 |
Surgical platform | .977 | ||
Robot (n) | 5 (17.9%) | 2 (13.3%) | |
Laparoscopy (n) | 7 (25.0%) | 5 (33.3%) | |
Laparotomy (n) | 16 (57.1%) | 8 (53.3%) | |
Endometrium distortion (n) | 10 (35.7%) | 8 (53.3%) | .264 |
Adenomyosis type | .073 | ||
Focal (n) | 4 (14.3%) | 6 (40.0%) | |
Diffuse (n) | 24 (85.7%) | 9 (60.0%) | |
Transfusion (n) | 19 (67.9%) | 6 (40.0%) | .078 |
Combined disease | |||
Endometriosis (n) | 8 (28.6%) | 8 (53.3%) | .109 |
Combined leiomyoma (n) | 12 (42.9%) | 6 (40.0%) | .856 |
Size of myoma, cm | 2.5 (1.0–5.9) | 2.2 (1.0–4.9) | .553 |
Number of myoma | 2 (1–4) | 2 (1–3) | .892 |
Endometriosis size, cm | 4.6 (1.0–10.0) | 3.5 (1.0–8.5) | .755 |
ASRM stage | 4 (1–4) | 4 (3–4) | .755 |
IVF history (n) | 25 (89.3%) | 12 (80.0%) | 1.00 |
The number of pregnancy trial after surgery | 2 (0–5) | 1 (0–4) | .848 |
Follow-up duration, mo | 18.5 (3–42) | 12.0 (6–38) | .256 |